Navigation Links
AWT Management Announce Aggressive Growth and Acquisition Strategy
Date:9/7/2007

SOMERSET, N.J., Sept. 7 /PRNewswire-FirstCall/ -- AWT, Inc. (Pink Sheets: AWTM), a distributor of state-of-the-art medical equipment to the healthcare industry, announced today an aggressive revenue growth and acquisition strategy for the next 36 months. "With the new management team and board of directors in place, the company felt it necessary to let its shareholders know of the future of their investments," stated Christopher J. Neill, CEO. Continuing his statement, "Part of our Strategy is continually researching the market for new opportunities in acquisitions, new state-of- the-art equipment, new joint ventures, or simply increasing sales. Bringing these and additional areas of business together we feel will enhance shareholder value, and for the first third of our strategy, we have identified several acquisition targets for our focus."

The Company is presently in process of closing the first of several planned and in-process acquisitions. "As we finish this first acquisition and after we implement cost controls, AWT should show an approximate 30% increase in top line revenue and a 35% increase to the bottom line net income for this particular asset. That would mean a net of $202,500 for the acquisition which would more than cover the cost of it in the first year by approximately two fold", commented Mr. Neill, CEO. Final terms are currently being negotiated and the Company hopes to close within 30 days.

"AWT's revenue growth strategy for the healthcare industry overall is about reducing costs while keeping the margins high. The premise of having a core infrastructure of state-of-the-art technologies, methodologies, or processes, is to reduce costs for the clients you are servicing. By combining both core and associated technology and processes your overall cost reduces, allowing you to service clients at a lower cost to them and a higher margin to the Company," stated Ravi Saini, Chairman of the Board.

AWT expects to add 4 more execut
'/>"/>

SOURCE AWT, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New Modality in Migraine Management
2. Self-Management Program Beneficial for Back Pain
3. Self-Management Program Beneficial for Back Pain
4. Disease Management Programs – Effective for Heart Patient
5. Effective Management Of Heart Patients
6. New advance in prostate cancer management
7. Gastrin, Much More Than The Weight Management Hormone
8. Medical Management Now Available For Miscarriage
9. Early Awareness About Weight Management Needed To Tackle Lifelong Obesity
10. Exercise For Effective Pain Management In Old People
11. Glimepiride in the medical management of Type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...nancial implications of SSDI benefits, online fina...h disabilities. , Bellevi...to move forward after a diagnosis of a long-term d... that individuals do as much as they can to unders.../www.allsup.com/ [Allsup], which represents peopl...
(Date:8/28/2008)... - Nine new Centers opened to date in 2008 VAN...al Corporation,(CRM:TSX-V) announced today unaudit... 30, 2008 (all figures are in US dollars). Revenue...d 138% to $1,653,891 compared to,$695,994 for the ...ded June,30, 2008 increased 150% to $3,001,333 com...
(Date:8/28/2008)...ecially for the impaired, study says , ,... says that 13 percent of American seniors suffer m... University of Chicago researchers said the chief ...dvantage of financially (3.5 percent), and physica...niors with physical impairments were most likely t...
(Date:8/28/2008)... Guava Technologies, Inc.,announced the commenceme...ovide drug discovery researchers with an automated...e agreement is a key component of a larger,strateg...e is a direct,response to a voiced need for sophis... throughput research in a compact, automated, and ...
Breaking Medicine News(10 mins):Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:13% of Seniors Report Being Mistreated 2Health News:San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research 2Health News:San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research 3
...the celebration of Mother’s day reveals a sad pict...g to the statistics released by UNICEF// in India ... compared to the world scenario this accounts to m... India for every 100 000 live births there are abo...
...edical students across the country shows the angui...e country against the government's policy for rese...cal colleges, IITs or IIMs. // The protests are g...edicos the IIT students also have decided to join ...
...Service for Wales (NPHS) has announced that the ac...y rare after a caseworker was apparently diagnosed...0 patients in Gwynedd are to be screened for the v...risk to patients and is preparing a comprehensive ...
...re urged by the experts to concentrate on organic ...les, which has been alarmingly dropping due to the...Swiss and Indian experts who have just ended their...te to raise awareness about the need for adopting ...
Other Medicine News:Health News:UNICEF Facts & Figures About Maternal Death In India On The Eve Of Mother’s Da 2Health News:UNICEF Facts & Figures About Maternal Death In India On The Eve Of Mother’s Da 3Health News:Merciless Lathi Charge of our Meritorious Medicos 2Health News:Organic Farming May Increase The Output Of Apples In Himachal 2
(Date:8/27/2008)..., from BLISS-52 trial, expected by mid-2009 - - D...by fall 2009 -, ROCKVILLE, Md., Aug. 27 /PRNewswi...aq: HGSI ) today announced it has completed enrol...f two pivotal Phase 3,randomized clinical trials o...ive systemic lupus erythematosus (SLE). Belimumab ...
(Date:8/26/2008)...ents can drive safely six weeks following surgical...SNewswire/ -- Six weeks following,bunion surgery, ...e able to,get back behind the wheel of a car again...e Journal of Bone and Joint Surgery ( http://www.j...sponse in patients who underwent a,first metatarsa...
(Date:8/26/2008)...ewswire/ -- Omeros Corporation today announced the... trial investigating,OMS103HP in arthroscopic ante...y. OMS103HP is an investigational drug product tha... is designed to improve postoperative,knee functio...patients an,earlier return to work. The article ti...
(Date:8/25/2008)...g. 25 /- Anthera Pharmaceuticals,Inc....oping,anti-inflammatory drugs, today announced the...coronary events with Near-term Cardiovascular,Infl...xamine the impact of,varespladib when administered...Syndrome (ACS) event., The FRANCIS trial is desig...
Breaking Medicine Technology:Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Braking After Bunion Surgery 2Braking After Bunion Surgery 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Shaking may cause brain damage and serious long term effects to infants 1376 1Shaking may cause brain damage and serious long term effects to infants 1376 2American College of Physicians publishes The Fenway Guide to LGBT Health 1374 1American College of Physicians publishes The Fenway Guide to LGBT Health 1374 2IMPACT initiative looks to improve patient participation in clinical trials 1372 1IMPACT initiative looks to improve patient participation in clinical trials 1372 2New genetic research into nicotine addiction shows promise for personalized treatment 421 1New genetic research into nicotine addiction shows promise for personalized treatment 421 2
...esented at ASCO with cediranib - a selective,VEGF ...ents alive,and progression- free at six months(1),...he,investigational agent cediranib (AZD2171) were ...can Society of Clinical Oncology,(ASCO) from a stu...an invasive form of brain tumor with a high unmet ...
...atients With Follicular Lymphoma Reported,Today at.../PRNewswire/ -- GlaxoSmithKline plc,announced toda... a,single one-week course of frontline treatment w... and Iodine I-131 Tositumomab) in,76 patients with...,lymphoma (NHL). This regimen was found to induce ...
Other Medicine Technology:Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 2Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 3Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
A direct qualitative enzyme immunoassay for detection of E.coli Shiga Toxin 1 and 2 in fresh or preserved fecal specimens.
The Directigen™ Meningitis Individual Tests are presumptive latex slide agglutination tests for the direct qualitative detection of antigens to H. influenzae type b, S. pneumoniae, N. meningitid
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease).
The AP250 Auto Projector is a remote-controlled, programmable, random-access, high-resolution, ophthalmic projector.
Medicine Products: